80 related articles for article (PubMed ID: 21512429)
1. Poor outcomes associated with neutropenia after kidney transplantation: analysis of United States Renal Data System.
Hurst FP; Belur P; Nee R; Agodoa LY; Patel P; Abbott KC; Jindal RM
Transplantation; 2011 Jul; 92(1):36-40. PubMed ID: 21512429
[TBL] [Abstract][Full Text] [Related]
2. The use of granulocyte colony-stimulating factor in a neutropenic renal transplant recipient.
Derici U; Ayerdem F; Arinsoy T; Reis KA; Dalgic A; Sindel S
Haematologia (Budap); 2002; 32(4):557-60. PubMed ID: 12803133
[TBL] [Abstract][Full Text] [Related]
3. Incidence, predictors, costs, and outcome of renal cell carcinoma after kidney transplantation: USRDS experience.
Hurst FP; Jindal RM; Graham LJ; Falta EM; Elster EA; Stackhouse GB; Agodoa LY; Lentine KL; Salifu MO; Abbott KC
Transplantation; 2010 Oct; 90(8):898-904. PubMed ID: 21248500
[TBL] [Abstract][Full Text] [Related]
4. Use of granulocyte-macrophage colony-stimulating factor in leukopenic renal transplant recipients.
Page B; Morin MP; Mamzer MF; Thervet E; Legendre C
Transplant Proc; 1994 Feb; 26(1):283. PubMed ID: 8108982
[No Abstract] [Full Text] [Related]
5. Acute respiratory distress syndrome after kidney transplantation: epidemiology, risk factors, and outcomes.
Shorr AF; Abbott KC; Agadoa LY
Crit Care Med; 2003 May; 31(5):1325-30. PubMed ID: 12771598
[TBL] [Abstract][Full Text] [Related]
6. Use of granulocyte-macrophage colony-stimulating factor for reversal of neutropenia following combined kidney-pancreas transplantation.
Squiers EC; Elkhammas EA; Henry ML
Transplant Proc; 1995 Dec; 27(6):3092-3. PubMed ID: 8539860
[No Abstract] [Full Text] [Related]
7. Comparison of hospitalization risk and associated costs among patients receiving sargramostim, filgrastim, and pegfilgrastim for chemotherapy-induced neutropenia.
Heaney ML; Toy EL; Vekeman F; Laliberté F; Dority BL; Perlman D; Barghout V; Duh MS
Cancer; 2009 Oct; 115(20):4839-48. PubMed ID: 19637341
[TBL] [Abstract][Full Text] [Related]
8. Granulocyte-colony stimulating factors for secondary prevention of leucopenia in patients receiving chemotherapy.
Lowathanasirikul J; Manusirivithaya S; Tangjitgamol S; Leelahakorn S
J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S47-53. PubMed ID: 17726809
[TBL] [Abstract][Full Text] [Related]
9. Use of granulocyte colony-stimulating factor for neutropenia after orthotopic liver transplantation: report of two cases.
Atici AE; Bostanci EB; Ozer I; Ulas M; Akdogan M; Akoglu M
Transplant Proc; 2011 Apr; 43(3):909-11. PubMed ID: 21486626
[TBL] [Abstract][Full Text] [Related]
10. Granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and other immunomodulatory therapies for the treatment of infectious diseases in solid organ transplant recipients.
Page AV; Liles WC
Curr Opin Organ Transplant; 2008 Dec; 13(6):575-80. PubMed ID: 19060545
[TBL] [Abstract][Full Text] [Related]
11. Advances in the use of colony-stimulating factors for chemotherapy-induced neutropenia.
Dale DC
J Support Oncol; 2005; 3(2 Suppl 1):39-41. PubMed ID: 15794500
[No Abstract] [Full Text] [Related]
12. Neutropenic complications in advanced-stage non-Hodgkin's lymphoma: implications for the use of prophylactic recombinant human granulocyte-colony stimulating factor (G-CSF).
Bobey N; Woodman RC
Clin Invest Med; 1998 Apr; 21(2):63-70. PubMed ID: 9562926
[TBL] [Abstract][Full Text] [Related]
13. Associations of pretransplant diabetes mellitus, new-onset diabetes after transplant, and acute rejection with transplant outcomes: an analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing (OPTN/UNOS) database.
Kuo HT; Sampaio MS; Vincenti F; Bunnapradist S
Am J Kidney Dis; 2010 Dec; 56(6):1127-39. PubMed ID: 20934793
[TBL] [Abstract][Full Text] [Related]
14. Risk of lymphoma after renal transplantation varies with time: an analysis of the United States Renal Data System.
Smith JM; Rudser K; Gillen D; Kestenbaum B; Seliger S; Weiss N; McDonald RA; Davis CL; Stehmen-Breen C
Transplantation; 2006 Jan; 81(2):175-80. PubMed ID: 16436959
[TBL] [Abstract][Full Text] [Related]
15. Risk of fractures after renal transplantation in the United States.
Nikkel LE; Hollenbeak CS; Fox EJ; Uemura T; Ghahramani N
Transplantation; 2009 Jun; 87(12):1846-51. PubMed ID: 19543063
[TBL] [Abstract][Full Text] [Related]
16. The use and effectiveness of granulocyte colony-stimulating factor in primary prophylaxis for febrile neutropenia in the outpatient setting.
Tuffaha HW; Treish IM; Zaru L
J Oncol Pharm Pract; 2008 Sep; 14(3):131-8. PubMed ID: 18524866
[TBL] [Abstract][Full Text] [Related]
17. Depressive disorder in renal transplantation: an analysis of Medicare claims.
Dobbels F; Skeans MA; Snyder JJ; Tuomari AV; Maclean JR; Kasiske BL
Am J Kidney Dis; 2008 May; 51(5):819-28. PubMed ID: 18436093
[TBL] [Abstract][Full Text] [Related]
18. Pretransplant donor-specific antibodies detected by single-antigen bead flow cytometry are associated with inferior kidney transplant outcomes.
Singh N; Djamali A; Lorentzen D; Pirsch JD; Leverson G; Neidlinger N; Voss B; Torrealba JR; Hofmann RM; Odorico J; Fernandez LA; Sollinger HW; Samaniego M
Transplantation; 2010 Nov; 90(10):1079-84. PubMed ID: 21293194
[TBL] [Abstract][Full Text] [Related]
19. Granulocyte colony-stimulating factor. A new application for cytomegalovirus-induced neutropenia in cardiac allograft recipients.
Patel HD; Anderson JR; Duncombe AS; Carrington D; Murday A
Transplantation; 1994 Oct; 58(7):863-7. PubMed ID: 7940727
[No Abstract] [Full Text] [Related]
20. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
Wong SF; Chan HO
Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
